Researchers have found in a new study that introduction of baby formula within the first three days of life significantly increases the risk of developing peanut and multiple food allergies. The study emphasizes the vital role of colostrum, rich in immune-boosting bioactive compounds in supporting infant gut and immune health, benefits that are absent in […]
China: A recent study leveraging data from the National Health and Nutrition Examination Survey (NHANES) has revealed that individuals with depression face a significantly higher risk of developing obstructive sleep apnea (OSA). Published in BMC Psychiatry, the research was conducted by Xiangyang Cheng from the Department of Anesthesiology, The First Affiliated Hospital, Zhejiang University School […]
Radiation therapy may offer a comparable and potentially safer alternative to repeat catheter ablation for patients with severe abnormal heart rhythms that can no longer be controlled with medication. In the first study to directly compare cardiac radiation with standard catheter ablation for ventricular tachycardia, patients treated with cardiac radiation experienced fewer complications with similar […]
The FDA has accepted MannKind’s supplemental biologics license application (sBLA) for Afrezza (insulin human inhalation powder) to treat children and adolescents with type 1 or type 2 diabetes, with a PDUFA target date of May 29, 2026. The phase 3 INHALE-1 trial demonstrated Afrezza’s noninferiority to multiple daily injections, showing comparable safety and no significant […]
Researchers have found in a new study that among patients undergoing valve-in-valve transcatheter aortic procedures, antiplatelet therapy type Dual Versus Single, had little effect on major ischemic or bleeding outcomes at one year, though dual antiplatelet therapy (DAPT) may modestly reduce stroke risk. The study was published in JACC: Cardiovascular Interventions by Francesco B. and […]
A new study published in Epidemiological Review reports that the prevalence of oral potentially malignant disorders (OPMDs) in central India is notably higher than global averages, with tobacco and areca nut use identified as the primary contributing factors. The researchers found a prevalence rate of 7.57%, underscoring a substantial public health concern in this region. […]
China: A phase 3 clinical trial has shown that dotinurad, a selective urate reabsorption inhibitor, is more effective than febuxostat in reducing serum uric acid levels in Chinese patients with gout while maintaining a comparable safety profile. The findings, published in Arthritis & Rheumatology, suggest that dotinurad may provide a new treatment option for individuals […]
Gwalior: In a stern move aimed at tightening pharmaceutical regulation, the Chief Medical and Health Officer (CMHO) of Gwalior, Dr Sachin Srivastava, has warned that dispensing medicines without the supervision of a registered pharmacist will now attract strict legal action, including imprisonment. The directive comes as part of a wider crackdown on unlicensed medical practices […]
Indore: After the tragic deaths of several children allegedly linked to contaminated cough syrups in Chhindwara and Betul, Madhya Pradesh’s pharmaceutical industry has come under intense scrutiny. The Madhya Pradesh Food and Drug Administration (MPFDA) has placed 30 drug manufacturing companies under investigation, launching a sweeping crackdown in collaboration with the Central Drugs Standard Control […]
New Delhi: The Delhi High Court has granted an ex-parte ad-interim injunction in favour of Sun Pharmaceutical Medicare, a subsidiary of Sun Pharmaceutical Industries, restraining Alenvision Pharma and its associate company from manufacturing or marketing their migraine drug under the mark NEXADOM, which the court found deceptively similar to Sun Pharma’s registered trademark NAXDOM. The […]